Drug – bio-affecting and body treating compositions – Bleach for live hair or skin
Reexamination Certificate
2003-07-22
2009-02-24
Channavajjala, Lakshmi S (Department: 1611)
Drug, bio-affecting and body treating compositions
Bleach for live hair or skin
C424S401000, C424S725000
Reexamination Certificate
active
07494643
ABSTRACT:
The present invention relates to novel, topically applied, cosmetic/dermatological compositions for the treatment of hyperpigmentation disorders and photodamaged human skin. The subject compositions combat hyperpigmented skin. In addition, the compounds described can be used in the treatment of many other pathologies. Due to a high degree of gentleness, along with potent antioxidant and moisturizing effects, the present invention can be used safely in the treatment of many conditions, such as the prevention and/or treatment of melasma, freckles, age spots (lentigo senilis) and photodamaged skin.
REFERENCES:
patent: 5053230 (1991-10-01), Gazzani
patent: 5116605 (1992-05-01), Alt
patent: 5202313 (1993-04-01), Bombardelli et al.
patent: 5268176 (1993-12-01), Znaiden et al.
patent: 5358716 (1994-10-01), Laugier et al.
patent: 5391550 (1995-02-01), Carniglia et al.
patent: 5556887 (1996-09-01), Lerner
patent: 5607980 (1997-03-01), McAtee et al.
patent: 5637304 (1997-06-01), Salini
patent: 5665364 (1997-09-01), McAtee et al.
patent: 5738856 (1998-04-01), Korb et al.
patent: 5837255 (1998-11-01), Inman et al.
patent: 5851543 (1998-12-01), Korb et al.
patent: 5877209 (1999-03-01), Yunis
patent: 5962517 (1999-10-01), Murad
patent: 5998485 (1999-12-01), Tyan et al.
patent: 6106850 (2000-08-01), Simon et al.
patent: 6190678 (2001-02-01), Hasenoehrl et al.
patent: 6300369 (2001-10-01), Ancira
patent: 2004/0137077 (2004-07-01), Ancira et al.
patent: 2700268 (1994-07-01), None
patent: 200351722 (2000-12-01), None
patent: WO 94/15626 (1994-07-01), None
Abstract—Sasson et al.; Growth and Bone Mineralisation as Affected by Dietary Calcium, Phytic Acid and Vitamin D; Comp Biochem Physiol A; 72(1); Jan. 1, 1982; pp. 43-48.
Abstract—MacFoy et al.; Medicinal Plants in Pujehun District of Sierra Leone; J. Enthnopharmacol.; 8(2); Aug. 1, 1983; pp. 215-223.
Abstract—Jeziorek et al.; A Theoretical Study of the Mechanism of Oxygen Binding by Model Anthraquinones. Part II. Quantum-mechanical studies of the energetics of oxygen binding to model anthraquinones.; Anticancer Drug Des; 8(3); Jun. 1, 1993; pp. 223-235.
Abstract—Pollack et al.; Mechanism of Inositol Monophosphatase, the Putative Target of Lithium Therapy; Proc Natl Acad Sci USA; 21;91(13) Jun. 1994; 5738-9.
Abstract—Nakagawa et al.; Contact allergy to kojic acid in skin care products; Contact Dermatitis; 32(1); Jan. 1, 1995; pp. 9-13.
Abstract—Atack et al.; Inositol Monophosphate—a putative target for Li+ in the treatment of biopolar disorder; Trends Neurosci; 18(8); Aug. 1, 1995; pp. 343-349.
Abstract—Kroser et al.; Risk factors for the development of colorectal carcinoma and their modification; Hematol Oncol Clin North Am; 11(4); Aug. 1, 1997; pp. 547-577.
Abstract—Bravo; Acido Kojico: Un Neuvo Despigmentante; Rev. Chilena Dermatol.; 13(3); 1997; pp. 186-189.
Abstract—Pugliese et al.; The Skin's Antioxidant Systems; Dermatol Nurs; 10(6); Dec. 1, 1998; pp. 417-418.
Abstract—Fuller et al.; Vismiaphenones D-G, new prenylated benzophenones from Vismia cayennensis; J Nat Prod; 62(1); Jan. 1, 1999; pp. 67-69.
Abstract—Lim; Treatment of Melasma using Kojic Acid in a Gel Containing Hydroquinone and Glycolic Acid; Dermatol Surg; 25(4); Apr. 1, 1999; pp. 282-284.
Abstract—Jin et al.; Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different mechanism of action; Arch Pharm Res; 22(3); Jun. 1, 1999; pp. 232-236.
Abstract—Nickel et al.; Inositol hexaphosphate reduces 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase independent of protein kinase C isoform expression in keratinocytes; Cancer Letters; 140(1-2); Jun. 1, 1999; pp. 105-111.
Abstract—Ishikawa et al.; Inhibition of skin cancer by IP6 in vivo: initiation-promotion model; Anticancer Res; 19(5A); Sep. Oct. 1999; pp. 3749-3752.
Abstract—Barker et al.; Inositol hexakisphosphate and beta-cell stimulus-secretion coupling; Anticancer Res; 19(5A); Sep. Oct. 1999; pp. 3737-3741.
Abstract—Shamsuddin; Metabolism and cellular functions of IP6: a review; Anticancer Res; 19(5A); Sep. Oct. 1999; pp. 3733-3736.
Abstract—Jenab et al.; Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis; Carcinogenesis; 21(8); Aug, 1, 2000; pp. 1547-1552.
Akerman & Senterfitt
Channavajjala Lakshmi S
Dobbelaere Amy A.
Steele, Jr. J. Rodman
LandOfFree
Method and topical composition for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and topical composition for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and topical composition for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108809